Results 231 to 240 of about 11,213,687 (295)

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

Molecular Oncology, EarlyView.
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen   +3 more
wiley   +1 more source

Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial. [PDF]

Transl Oncol
Chia DKA, Demuytere J, Hoorens A, De Meuleneir K, Cosyns S, Van der Speeten K, Liberale G, Vansteenkiste F, Willaert W, Ceelen W.   +9 more
europepmc   +1 more source

TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial. [PDF]

Clin Cancer Res
Xu C, Wang SY, Nie M, Yang KY, Huang XQ, Qu S, Chen H, Shen LF, Huang J, Zhang F, Peng YP, Shi LL, Hong XH, Zhang ZJ, Tang LL, Guo L, Ouyang PY, Gao JM, Mao YP, Huang Y, Guo R, Liu LZ, Tian L, Li HJ, Li JB, Ma J, Xia Y, Cai QQ.   +27 more
europepmc   +1 more source

Byron II luncheon menu

, 2012
Byron II (Restaurant)
core  

A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. [PDF]

Alzheimers Dement
Martens CR, Decker KP, DeConne TM, Sanjana F, Horvat F, Rizzi NA, Awad C, Habash E, Hobson JC, Kramer MK, Armstrong ML, Reisdorph N, Pohlig RT, Lanzi AM, Johnson CL, Cohen ML, Ellison JM.   +16 more
europepmc   +1 more source

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II. [PDF]

Leukemia
Beird HC, Kannan S, Liu J, Chen J, Olguin A, Desai P, Cai T, Han L, Cotton JL, Singh S, Gupta SK, Little L, Estecio MR, Song X, Abbas HA, Zhang J, Gumbs C, Brooks C, Kantarjian H, Andreeff M, Konopleva M, Futreal PA, Pemmaraju N.   +22 more
europepmc   +1 more source

Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial. [PDF]

Stroke Vasc Neurol
Feng B, Li H, Xu S, Li J, Wang Y, Zhao X, Wei Y, Xiao X, Wang S, Wang Y, Li S.   +10 more
europepmc   +1 more source

Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind, placebo-controlled phase II trial

, 2001
LAVELLE JF, ON BEHALF OF THE GAIN PHASE II EUROPEAN STUDY GROUP, CAROLEI, ANTONIO, SANDERS EACM, LEES KR, WESTER P, CUNHA L, DIENER HC, TACK P   +8 more
core